Alerts will be sent to your verified email
Verify Email
SENORES
|
Senores Pharmaceutic
|
Ajanta Pharma
|
Alembic Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Number of ANDA's Approved
|
61.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
10.71 % | 5.0 % | 9.0 % |
|
Financials
|
|||
|
5 yr Average ROE
|
12.21 % | 21.63 % | 12.89 % |
|
5yr average Equity Multiplier
|
2.48 | 1.32 | 1.39 |
|
5yr Average Asset Turnover Ratio
|
0.29 | 0.84 | 0.86 |
|
5yr Avg Net Profit Margin
|
15.17 % | 19.77 % | 11.15 % |
|
Price to Book
|
3.42 | 8.26 | 3.84 |
|
P/E
|
45.91 | 34.01 | 34.18 |
|
5yr Avg Cash Conversion Cycle
|
-69.14 Days | -102.34 Days | 9.46 Days |
|
Inventory Days
|
47.61 Days | 55.16 Days | 99.1 Days |
|
Days Receivable
|
114.09 Days | 49.8 Days | 66.32 Days |
|
Days Payable
|
279.35 Days | 195.69 Days | 164.9 Days |
|
5yr Average Interest Coverage Ratio
|
4.49 | 108.5 | 30.59 |
|
5yr Avg ROCE
|
10.49 % | 27.48 % | 15.26 % |
|
5yr Avg Operating Profit Margin
|
23.01 % | 27.65 % | 17.29 % |
|
5 yr average Debt to Equity
|
0.98 | 0.0 | 0.14 |
|
5yr CAGR Net Profit
|
99.71 % | 7.08 % | -12.64 % |
|
5yr Average Return on Assets
|
4.43 % | 16.51 % | 9.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
45.77 % | 66.26 % | 69.67 % |
|
Share Pledged by Promoters
|
0.0 | 12.61 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.01 % | -4.22 % | 0.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-2.39 % | 4.63 % | 4.02 % |
|
Senores Pharmaceutic
|
Ajanta Pharma
|
Alembic Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|